Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity - a [11C]DASB PET study.
about
Meta-analysis of molecular imaging of serotonin transporters in major depressionThe aggression and behavioral abnormalities associated with monoamine oxidase A deficiency are rescued by acute inhibition of serotonin reuptake.Abnormalities of white matter microstructure in unmedicated obsessive-compulsive disorder and changes after medicationInvasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCDCaloric restriction enhances fear extinction learning in miceSerotonergic modulation of suicidal behaviour: integrating preclinical data with clinical practice and psychotherapy.5-HT radioligands for human brain imaging with PET and SPECTCentral serotonin transporter levels are associated with stress hormone response and anxiety.The neurocircuitry of fear, stress, and anxiety disordersWhat have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?Amisulpride-induced acute akathisia in OCD: an example of dysfunctional dopamine-serotonin interactions?Brain regional α-[11C]methyl-L-tryptophan trapping in medication-free patients with obsessive-compulsive disorder.Motivation and value influences in the relative balance of goal-directed and habitual behaviours in obsessive-compulsive disorder.Alterations of white matter fractional anisotropy in unmedicated obsessive-compulsive disorder.An updated review of antidepressants with marked serotonergic effects in obsessive-compulsive disorder.A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models.Obsessive-compulsive disorder: Insights from animal models.Excessive nest building is a unique behavioural phenotype in the deer mouse model of obsessive-compulsive disorder.Social behavior in deer mice as a novel interactive paradigm of relevance for obsessive-compulsive disorder (OCD).Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder.Peromyscus maniculatus bairdii as a naturalistic mammalian model of obsessive-compulsive disorder: current status and future challenges.Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [11 C]DASB PET study.Mapping Compulsivity in the DSM-5 Obsessive Compulsive and Related Disorders: Cognitive Domains, Neural Circuitry, and Treatment.Different patterns of 5-HT receptor and transporter dysfunction in neuropsychiatric disorders--a comparative analysis of in vivo imaging findings.The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.Monoamine abnormalities in the SAPAP3 knockout model of obsessive-compulsive disorder-related behaviour.
P2860
Q24289345-7612832F-1017-4156-B36F-736970D96EDCQ28391257-B1CB3431-B6AC-425A-AD87-0BF87C3721BEQ28482864-F52FA969-D66C-4641-9927-90206292C6D8Q30498546-173B97B6-2079-47A6-AEC3-025CA75BE107Q30538952-6C73BDC2-7389-4C8C-825A-A9AA1ED7F831Q30663345-C9B654ED-AE90-44CB-B8D4-537B67F3E41DQ34192729-EB4C791C-DBCF-43F6-94F6-9678943FD1E8Q34441012-064AD59E-3299-42FB-B65C-1F6CE5C1D6D2Q34660882-D0A26F39-8741-4F06-99BE-008E9FA6D474Q35195505-4F6E1DC4-769C-48EC-90B2-EA632F489228Q36878354-4A4E972B-8D24-4016-B07C-C3D82F7E4B9CQ36916929-0379E545-B195-4822-A152-FF4E2E53322EQ37347640-A90496EA-AA26-4736-A194-92BD115EF737Q37551875-C35BBD27-8D55-4F33-964A-4CFAAC5F93D8Q38207094-24296F21-E64D-4473-A92E-37094E218B6AQ38630519-35033CB1-9AC3-45D8-B49C-5B1DAFFD0C29Q38832138-168DE817-852A-4027-B56D-0B1B8DBC8337Q39786914-16E4C906-30F2-4814-8800-9ACC513EB4DAQ40047762-0DFE0DA0-8704-4AF4-A4F3-60F4E3825502Q46691558-366AD4E8-3B4F-4EEB-9975-3D6EC82F9B03Q47566821-16F613AE-437E-440C-89B5-EC56AED54140Q47930478-54852CBC-7B10-4094-AEA0-4FCC5DABB0D9Q48016660-3BDAAFD6-F6AA-4A61-8686-FF907F7E391EQ48074706-8BE4F103-6E0D-455C-992D-5527619BD29AQ48930306-1D409BD3-F7BD-4CBA-BDA4-952D6E660246Q50561917-32DBCAE7-804A-4B19-8C4B-109948D058B8Q53468951-F2057C08-4D53-4DC3-BC00-FA9925C24382
P2860
Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity - a [11C]DASB PET study.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Reduced availability of seroto ...... erity - a [11C]DASB PET study.
@ast
Reduced availability of seroto ...... erity - a [11C]DASB PET study.
@en
Reduced availability of seroto ...... erity - a [11C]DASB PET study.
@nl
type
label
Reduced availability of seroto ...... erity - a [11C]DASB PET study.
@ast
Reduced availability of seroto ...... erity - a [11C]DASB PET study.
@en
Reduced availability of seroto ...... erity - a [11C]DASB PET study.
@nl
prefLabel
Reduced availability of seroto ...... erity - a [11C]DASB PET study.
@ast
Reduced availability of seroto ...... erity - a [11C]DASB PET study.
@en
Reduced availability of seroto ...... erity - a [11C]DASB PET study.
@nl
P2093
P2860
P50
P1476
Reduced availability of seroto ...... verity - a [11C]DASB PET study
@en
P2093
H U Smoltczyk
H-J Machulla
P2860
P2888
P304
P356
10.1007/S00702-007-0785-6
P577
2007-08-22T00:00:00Z